Bessent Says Some ‘Sectors’ Of Economy Are In Recession 65-year-old retirees in France now have higher incomes than ...

Renowned cardiologist Dr. Jeremy London debunks viral heart attack myths like "cough CPR" and cayenne pepper remedies. He ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

The sudden death of 18-year-old student Vaishnav Krishnakumar in Dubai this week has left many families and medical professionals heartbroken. Many are questioning how such tragedies could happen to ...

New research indicates that limiting sugar intake during the first two years of life offers enduring heart benefits into adulthood. Published in the British Medical Journal (BMJ), a study found ...

Older adults don’t have to hit a high daily step count to reap serious benefits for their heart health, according to a new analysis. Older women who walked at least 4,000 steps one to two days per ...

Venoarterial extracorporeal membrane oxygenation (VA ECMO) can be used as an option for severe acute heart failure in adults as a bridge to recovery, a heart transplant or an implanted left ...

Evidence-based recommendations on venoarterial extracorporeal membrane oxygenation (VA ECMO) for severe acute heart failure in adults. This involves using an artificial lung to oxygenate the blood ...

Progression to more advanced stages of heart failure is common among older adults, especially those in earlier stages, according to new data presented at the Heart Failure Society of America (HFSA) ...

The Peyton Walker Foundation, in partnership with York College, will host a free Adult Heart Screening, 9 a.m.-2 p.m. Saturday at the Grumbacher Sport and Fitness Center on campus. The event is open ...

WILKES-BARRE — Given that 2% of youths who receive heart screenings are diagnosed with an abnormality or concern, and 1% are diagnosed with a life-threatening heart condition, a free clinic on ...

Findings that evolocumab significantly reduced the risk of major adverse CV events in adults at high CV risk without prior heart attack or stroke vs placebo. Topline data were announced from a phase 3 ...